Current Diagnosis and Management of Primary Chylomicronemia-Reference-Cited by-同舟云学术

Current Diagnosis and Management of Primary Chylomicronemia

Published:2021-09-01 Issue:9 Volume:28 Page:883-904
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Okazaki Hiroaki¹,Gotoda Takanari²,Ogura Masatsune³,Ishibashi Shun⁴,Inagaki Kyoko⁵,Daida Hiroyuki⁶,Hayashi Toshio⁷,Hori Mika⁸,Masuda Daisaku⁹,Matsuki Kota¹⁰,Yokoyama Shinji¹¹,Harada-Shiba Mariko¹²

Affiliation:

1. Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo

2. Department of Metabolic Biochemistry, Faculty of Medicine, Kyorin University

3. Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute

4. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University

5. Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Nippon Medical School

6. Faculty of Health Science, Juntendo University, Juntendo University Graduate School of Medicine

7. School of Health Sciences, Nagoya University Graduate School of Medicine

8. Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University

9. Department of Cardiology, Health Care Center, Rinku Innovation Center for Wellness Care and Activities (RICWA), Rinku General Medical Center

10. Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine

11. Institute for Biological Functions, Chubu University

12. Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/9/28_RV17054/_pdf

Reference212 articles.

1. 1) Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. The metabolic and molecular bases of inherited disease, 2001; 2: 2789-2816

2. 2) Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N, Research Committee for Primary Hyperlipidemia, Research on Measures against Intractable Diseases by the Ministry of Health, Labour and Welfare in Japan. Diagnosis and management of type I and type V hyperlipoproteinemia. J Atheroscler Thromb, 2012; 19: 1-12

3. 3) Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Borén J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AFH, Stroes E, Taskinen M-RR, Tybjærg-Hansen A, Watts GF, Wiklund O, Panel EASC. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol, 2014; 2: 655-666

4. 4) Burnett JR, Hooper AJ, Hegele RA. Familial Lipoprotein Lipase Deficiency [Internet]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993 [cited 2019 Oct 28]. Available from: http: //www.ncbi.nlm.nih.gov/books/NBK1308/

5. 5) Brahm AJ, Hegele RA. Chylomicronaemia--current diagnosis and future therapies. Nat Rev Endocrinol, 2015; 11: 352-362

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Apolipoprotein C-III for the Management of Severe Hypertriglyceridemia: Current Research and Future Directions;Cureus;2024-08-17

2. Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia;JAMA Cardiology;2024-07-01

3. Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia – Case Report and Literature Review;Journal of Atherosclerosis and Thrombosis;2024-07-01

4. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency;Nutrition, Metabolism and Cardiovascular Diseases;2024-07

5. Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene;Acta Gastro Enterologica Belgica;2024-06